Diligence memo · auto-generated · as of July 2, 2026
Rose Diagnostics Inc.
Rose Diagnostics Inc. looks over-valued against its niche peers and is active on financing cadence.
Businessfiled
Rose Diagnostics Inc. operates in Medical Devices, based in CARLSBAD.
Sub-sector tags: medical-devices.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Rose Diagnostics Inc. has raised $3.3M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $2.3M on 2025-05-09.
Most recent recorded round closed around 2025-05-09.
Valuation (modeled)modeled
Provath models Rose Diagnostics Inc. at approximately $7.2M (range $1.9M–$15M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 4.09× the median modeled value of Seed Medical Devices companies in 2025–2027 (8 peers) — value vs value, same stage and era. Issuer reports no revenue, yet is modeled well above niche peers.
Financing rhythm & timingmixed
Historic cadence: a new round about every 11 months.
Last raise 14 mo ago; this sector typically re-raises about every 16 months.
Raising on or ahead of the sector's normal rhythm.
The last round stepped up 2.3× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 62% of Medical Devices peers (233 compared).
Modeled value ranks above 42% of those peers.
Closest niche peers: Pace Surgical, Inc., MemorialCare Surgical Center at Saddleback, LLC, Intu Diagnostics, Persperion Diagnostics Inc., Origami Surgical Inc..
Peoplefiled
5 named people on file across officers, directors and signatories.
Risks & flagsmixed
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.